NASA Logo
Human Research Roadmap
HRP
Exploration
Data
Home
|
HRP Goals and Objectives
|
Human Research Roadmap
|
HRP Organizational Structure
|
Acronyms
|
Reviews
|
Help
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Evidence
MDRP
Risks
Gaps
Tasks
Reports
Explore
Search
IM1: We do not know to what extent spaceflight alters various aspects of human immunity during spaceflight missions up to 6 months.
This Gap was split into the following Gaps:
IM-103: Evaluate for novel endogenous viral reactivation
IM-102: Evaluate the effects of altered atmospheric conditions such as elevated CO2 levels or mildly hypoxic exploration atmosphere on immune dysfunction.
IM-101: Evaluate the effects of deep-space radiation on immune dysfunction, as an additional hazard to the effects of psychophysiological stress and weightlessness.
Split Rationale
No rationale available.
Next
Previous
This gap can be found in the following Risk Approach Plans.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
NASA
Developer: Daniel Febus
Responsible NASA Official: Susan Torney
Contact HRP for a 508 compliant PDF
Budgets, Strategic Plans, and Accountability Reports
Equal Employment Opportunity Data Posted Pursuant to the No Fear Act
Information-Dissemination Policies and Inventories
Freedom of Information Act
President's Management Agenda
Privacy Policy & Important Notices
Inspector General Hotline
Contact HRP
Human Health and Performance DIR
Johnson Space Center
USA.gov
ExpectMore.gov